Healthcare -
Biotechnology - NASDAQ - US
$ 7.455
-0.432 %
$ 544 M
Market Cap
-10.48
P/E
ARVN - STOCK-BASED COMPENSATION
Stock-based Compensation ARVN - Arvinas, Inc.
88.2 M
LAST VALUE
8.08%
2 YEAR CAGR
34.45%
5 YEAR CAGR
0.00%
10 YEAR CAGR